- The U.S. Veterans Administration (VA) has authorized its physicians to prescribe Johnson & Johnson (JNJ -0.1%) unit Janssen Pharmaceuticals' SPRAVATO (esketamine) nasal spray for veterans with depression.
- Eligible patients will allowed to self-administer the drug while under observation at certified medical facilities. The product will not be dispensed for home use.
VA to offer J&J's Spravato to veterans with depression
Recommended For You
More Trending News
About JNJ Stock
Related Stocks
| Symbol | Last Price | % Chg |
|---|---|---|
| JNJ | - | - |
| Johnson & Johnson | ||